Co-organized by School of Life Sciences (SLS) and the Gerald Choa Neuroscience Institute (GCNI), the first SLS/GCNI joint seminar was held at Cheng Yu Tung Building, The Chinese University of Hong Kong on October 29, 2024.
Prof. Kevin TALBOT, Head of the Nuffield Department of Clinical Neurosciences, University of Oxford, delivered a lecture titled “Key therapeutic targets underlying motor neuron degeneration in amyotrophic lateral sclerosis (ALS)”. Prof. Bruce RANSOM, Director of GCNI, and three additional GCNI Executive Committee members including Prof. Edwin CHAN, Prof. Owen Ho KO and Prof. Vincent CHEUNG attended the seminar.
The participants exchanged and discussed their experiences and insights in neuroscience research, particularly in the area of neurodegenerative diseases such as ALS. This inaugural joint seminar opens the door to exciting collaborative opportunities and lays the groundwork for SLS/GCNI joint seminar series.
Back
Oct 2024The first SLS/GCNI Joint Seminar
Co-organized by School of Life Sciences (SLS) and the Gerald Choa Neuroscience Institute (GCNI), the first SLS/GCNI joint seminar was held at Cheng Yu Tung Building, The Chinese University of Hong Kong on October 29, 2024.
Prof. Kevin TALBOT, Head of the Nuffield Department of Clinical Neurosciences, University of Oxford, delivered a lecture titled “Key therapeutic targets underlying motor neuron degeneration in amyotrophic lateral sclerosis (ALS)”. Prof. Bruce RANSOM, Director of GCNI, and three additional GCNI Executive Committee members including Prof. Edwin CHAN, Prof. Owen Ho KO and Prof. Vincent CHEUNG attended the seminar.
The participants exchanged and discussed their experiences and insights in neuroscience research, particularly in the area of neurodegenerative diseases such as ALS. This inaugural joint seminar opens the door to exciting collaborative opportunities and lays the groundwork for SLS/GCNI joint seminar series.